A Four-Year Cross-Sectional Analysis of Dyslipidemia Prevalence on the Pamirs Plateau - Report - MDSpire

A Four-Year Cross-Sectional Analysis of Dyslipidemia Prevalence on the Pamirs Plateau

  • By

  • Yisi Liu

  • Yue Shu

  • Xinyu Wang

  • Bin Li

  • Dai Su

  • Chaoji Huangfu

  • Zhu Huang

  • Yuxin Wang

  • Shuqian Zhang

  • Taiwei Wang

  • Chaoyue Gao

  • Lin Luo

  • Zexinyao Ren

  • Rui Wang

  • Yue Gao

  • Wei Zhou

  • December 29, 2025

  • 0 min

Share

Clinical Report: A Four-Year Cross-Sectional Analysis of Dyslipidemia Prevalence

Overview

This study investigates the prevalence and patterns of dyslipidemia among residents of the Pamirs Plateau over four years. It highlights significant variations in lipid profiles based on age, sex, and ethnicity in a high-altitude, multi-ethnic population.

Background

Incorporate statistics or findings from previous studies on dyslipidemia in high-altitude populations.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • The study is the first large-scale investigation of dyslipidemia in the Pamirs Plateau population.
  • It emphasizes the need to understand lipid profile variations according to demographic factors such as age, sex, and ethnicity.
  • Chronic high-altitude exposure may influence lipid metabolism differently across ethnic groups.
  • Socioeconomic transitions in the region may alter lifestyle patterns affecting health outcomes.
  • Data on dyslipidemia prevalence in high-altitude populations is limited, necessitating further research.

Clinical Implications

Healthcare providers should consider the unique environmental and ethnic factors influencing dyslipidemia in high-altitude populations. Tailored public health strategies are essential to address the specific needs of these communities, particularly as they undergo socioeconomic changes.

Conclusion

The findings underscore the importance of further research into dyslipidemia in high-altitude populations to inform effective health interventions. Understanding these dynamics is crucial for improving cardiovascular health outcomes in underserved regions.

References

  1. European Journal of Preventive Cardiology, 2023 -- Evaluation of lipid levels and lipid-lowering therapy by age and sex in dyslipidaemic Mexican population
  2. Clinical Research in Cardiology, 2010 -- Frequency and Co-occurrence of Various Lipid Abnormalities in Statin-Managed High Cardiovascular Risk Patients in Germany
  3. Relationship of Serum Lipid Levels to Colorectal Polyps: A Retrospective Cross-Sectional Analysis, 2023
  4. Clinical Research in Cardiology, 2023 -- Comprehensive Lipidomics Analysis Identifies Distinct Lipid Profiles Linked to Elevated Cardiovascular Risk
  5. Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association, 2026
  6. PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke | American Heart Association
  7. Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis - PMC
  8. Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association
  9. PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke | American Heart Association
  10. Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis - PMC

Original Source(s)

Related Content